{"id":"doxycycline-and-rifampin","safety":{"commonSideEffects":[{"rate":null,"effect":"Photosensitivity"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Drug interactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Doxycycline is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Rifampin inhibits bacterial RNA polymerase, blocking transcription. Together, this combination provides broad-spectrum antimicrobial activity against various pathogens, potentially including intracellular bacteria.","oneSentence":"Doxycycline and rifampin are a combination of two antibiotics that work synergistically to inhibit bacterial protein synthesis and RNA polymerase, respectively, to treat infections.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:09:59.141Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Investigational combination therapy for bacterial infections (specific indication under phase 3 evaluation not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT05074147","phase":"PHASE3","title":"Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)","status":"WITHDRAWN","sponsor":"Tourcoing Hospital","startDate":"2022-05-01","conditions":"Osteomyelitis - Foot","enrollment":""},{"nctId":"NCT05473520","phase":"PHASE3","title":"Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2023-05-24","conditions":"Tuberculosis, Acute Coronary Syndrome, Pulmonary Hypertension (Diagnosis)","enrollment":150},{"nctId":"NCT06446245","phase":"PHASE2","title":"Adjunctive Doxycycline for Central Nervous System Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-08-21","conditions":"Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System","enrollment":200},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT03378427","phase":"NA","title":"Tedizolid Prolonged Treatment for Prosthetic Joint Infections","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2018-08-28","conditions":"Prosthetic Joint Infection","enrollment":35},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT01438515","phase":"NA","title":"Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization","status":"COMPLETED","sponsor":"Horizon Health Network","startDate":"2008-08","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":100},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT00351273","phase":"PHASE3","title":"Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2006-05","conditions":"Arthritis, Reactive, Reiter Disease","enrollment":42},{"nctId":"NCT00439166","phase":"PHASE3","title":"Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2007-02","conditions":"Alzheimer's Disease","enrollment":100},{"nctId":"NCT02774993","phase":"PHASE2","title":"Doxycycline in Human Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2015-09","conditions":"Tuberculosis","enrollment":40},{"nctId":"NCT02123628","phase":"PHASE4","title":"Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2007-06","conditions":"Diabetes Mellitus","enrollment":40},{"nctId":"NCT00692588","phase":"","title":"MRI to Measure Treatment With Antibiotics in Alzheimer's Disease","status":"COMPLETED","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2008-06","conditions":"Alzheimer's Disease","enrollment":58},{"nctId":"NCT00715858","phase":"PHASE3","title":"A Pilot Study of Inflammatory Markers in Alzheimer's Disease","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2008-05","conditions":"Alzheimer's Disease","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":106,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Atridox and Rifadin"],"phase":"phase_3","status":"active","brandName":"Doxycycline and Rifampin","genericName":"Doxycycline and Rifampin","companyName":"University of South Florida","companyId":"university-of-south-florida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Doxycycline and rifampin are a combination of two antibiotics that work synergistically to inhibit bacterial protein synthesis and RNA polymerase, respectively, to treat infections. Used for Investigational combination therapy for bacterial infections (specific indication under phase 3 evaluation not publicly detailed).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}